Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q1 FY25 results · Apr–Jun 2024
Wockhardt reported revenue from operations of ₹739.00 crore (up 14.8% from Q1 FY24) and net loss of ₹16.00 crore for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 739.00 | 644.00 | +14.8% | 700.00 | +5.6% |
| Other income | 30.00 | 14.00 | +114.3% | 54.00 | −44.4% |
| Total income | 769.00 | 658.00 | +16.9% | 754.00 | +2.0% |
| Profit before tax | (6.00) | (118.00) | Loss narrowed | (180.00) | Loss narrowed |
| Net profit for the period | (16.00) | (136.00) | Loss narrowed | (177.00) | Loss narrowed |
| Attributable to shareholders of the company | (14.00) | (134.00) | Loss narrowed | (169.00) | Loss narrowed |
| EPS, basic (₹) | (0.95) | (9.28) | Loss narrowed | (11.64) | Loss narrowed |
| Net margin (%) | -2.2 | -21.1 | -25.3 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 352.00 | 251.00 | +40.2% | 355.00 | −0.8% |
| Other income | 27.00 | 6.00 | +350.0% | 24.00 | +12.5% |
| Total income | 379.00 | 257.00 | +47.5% | 379.00 | +0.0% |
| Profit before tax | 6.00 | (115.00) | Turned profit | (126.00) | Turned profit |
| Net profit for the period | 6.00 | (115.00) | Turned profit | (126.00) | Turned profit |
| EPS, basic (₹) | 0.39 | (8.01) | Turned profit | (8.71) | Turned profit |
| Net margin (%) | 1.7 | -45.8 | -35.5 |
Consolidated
- Filed with BSE
- 03 Sep 2024, 16:24 IST
- Board meeting
- 09 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Sep 2024, 16:24 IST
- Board meeting
- 09 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE